Verve Therapeutics SG&A Expense (Quarterly) Analysis

Verve Therapeutics Inc (VERV)

6.16 -0.26 (-4.05%) USD | NASDAQ | May 07, 12:58

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	12.28M
September 30, 2023	11.69M
June 30, 2023	13.42M
March 31, 2023	12.55M
December 31, 2022	11.44M
September 30, 2022	9.592M
June 30, 2022	9.067M
March 31, 2022	7.435M

Date	Value
December 31, 2021	6.601M
September 30, 2021	6.007M
June 30, 2021	3.541M
March 31, 2021	2.716M
December 31, 2020	2.024M
September 30, 2020	1.354M
June 30, 2020	1.032M
March 31, 2020	0.846M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.846M

Minimum

Mar 2020

13.42M

Maximum

Jun 2023

6.974M

Average

7.018M

Median

SG&A Expense (Quarterly) Benchmarks